Skip to main content
JW PHARMACEUTICAL logo

JW PHARMACEUTICAL — Investor Relations & Filings

Ticker · 001060 ISIN · KR7001060003 KO Manufacturing
Open in API
Filings indexed 310 across all filing types
Latest filing 2019-04-02 Annual Report
Country KR South Korea
Listing KO 001060

About JW PHARMACEUTICAL

https://www.jw-pharma.co.kr/pharma/en/m…

JW Pharmaceutical is a company focused on the research, development, and commercialization of pharmaceutical products. It provides a broad portfolio of therapeutic drugs, including specialty medicines and over-the-counter (OTC) solutions. Key product areas include nutritional infusions (Combiflex®, Winuf®), treatments for neutropenia (Neutrogin®), and cardiovascular medicines (Livalo®). Its consumer healthcare offerings feature the Hi-mom® brand of advanced wound care products. The company emphasizes innovation, advancing a pipeline of new drugs targeting oncology and immune diseases. This research is driven by proprietary technology platforms and includes candidates such as the gout treatment Epaminurad.

Recent filings

Filing Released Lang Actions
[기재정정]사업보고서 (2018.12)
Annual Report Classification · 95% confidence The document is a 'Correction Report' (정정신고) for an 'Annual Report' (사업보고서) filed by JW Pharmaceutical. It explicitly states it is a correction to a previously submitted annual report, providing updated tables for research and development expenses and other corporate details. Since it is a formal, comprehensive regulatory filing containing financial data and management information, it is classified as an Annual Report (10-K) under the provided schema. FY 2018
2019-04-02 Korean
사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Consolidated Audit Report' (연결감사보고서) for JW Pharmaceutical Corporation, covering the fiscal year 2018. It includes the independent auditor's report, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. Since it contains full financial statements and audit results for a specific fiscal period, it is classified as an Annual Report (10-K). FY 2018
2019-04-01 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment of an outside director (사외이사의 선임). This falls under the category of changes in the board of directors or senior management.
2019-03-29 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment of an outside director. The title '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' translates to 'Report on the Appointment, Dismissal, or Resignation of an Outside Director'. This falls under the category of board and management changes.
2019-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (AGM). It details the approval of financial statements, dividend declarations, and the election of board members. This falls directly under the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2019-03-29 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing from JW Pharmaceutical titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of the audit opinion (unqualified/appropriate) and key financial data (assets, liabilities, revenue, net income) for both consolidated and separate financial statements. While it contains financial data, it is a standard regulatory disclosure form used in the Korean market to announce the completion and submission of the audit report to the regulator, rather than the full annual report document itself. Given the structure and the nature of the disclosure, it fits the 'Audit Report / Information' category. FY 2018
2019-03-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.